Olympus Corporation of the Americas recalls ENF-GP2 Rhino-Laryngo Fiberscope - Product Usage: is indicated for use within the nasal and nasopharyngeal lumen.
- Recall date
- May 5, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2292-2020
- FDA classification
- Class II
- Brand / firm
- Olympus Corporation of the Americas
- Sold / distributed
- US Nationwide distribution including in the states of FL, MI, NM, NY, OH, and OR. No international distribution.
Why it was recalled
Products repaired with the incorrect service manual may be missing an O ring and are subject to rework with the corrected service manual.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
ENF-GP2 Rhino-Laryngo Fiberscope - Product Usage: is indicated for use within the nasal and nasopharyngeal lumen.
Get recall alerts
Free email alert whenever Olympus Corporation of the Americas has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Olympus Corporation of the Americas